Compound information
- Natural Products
- ZC1606035
- Molecular Formula
- C23H27N3O7S
- Molecular Weight
- 489.156971204 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-[4-[(4-ethoxycarbonylphenyl)carbamoyl]phenyl]sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C23H27N3O7S/c1-3-32-22(28)18-5-9-19(10-6-18)24-21(27)17-7-11-20(12-8-17)34(30,31)26-15-13-25(14-16-26)23(29)33-4-2/h5-12H,3-4,13-16H2,1-2H3,(H,24,27)
- InChI Key
- MDEXXNBUXHTEKU-UHFFFAOYSA-N
- SMILES
- CCOC(=O)c1ccc(NC(=O)c2ccc(S(=O)(=O)N3CCN(C(=O)OCC)CC3)cc2)cc1
- Source
- ZINC000011853066
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 34 | Ring Count | 3 |
Heteroatom Count | 11 | Rotatable Bond Count | 7 |
Hydrogen Bond Acceptor Count | 7 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 122.32 Å2 | LogP | 3.199 |
LogS | -5.479 | LogD | 3.318 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.063 | Pgp substrate | 0.292 |
HIA | 0.974 | F20 % | 0.15 |
F30 % | 0.207 | Caco-2 | -4.706 |
MDCK | -4.795 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.003 | PPB | 71.828 |
VD | 1.38 | Fu | 1.469 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.035 | CYP1A2 substrate | 0.588 |
CYP2A6 substrate | 0.561 | CYP2B6 substrate | 0.645 |
CYP2C19 inhibitor | 0.253 | CYP2C19 substrate | 0.786 |
CYP2C8 substrate | 0.651 | CYP2C9 inhibitor | 0.977 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.249 |
CYP2D6 substrate | 0.542 | CYP2E1 substrate | 0.235 |
CYP3A4 inhibitor | 0.042 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.436 | CL | 2.353 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.193 | Hepatotoxicity | 0.136 |
Mutagenicity | 0.008 | Rat Oral Acute Toxicity | 0.01 |
FDAMDD | 0.023 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.087 | Eye Corrosion | 0.001 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.001 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.882 | IGC50 | 3.938 |
LC50FM | -2.237 | LC50DM | -2.921 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.19 | NR-AR-LBD | 0.433 |
NR-AhR | 0.376 | NR-Aromatase | 0.068 |
NR-ER | 0.609 | NR-ER-LBD | 0.569 |
NR-PPAR-gamma | 0.209 | SR-ARE | 0.776 |
SR-ATAD5 | 0.416 | SR-HSE | 0.102 |
SR-MMP | 0.33 | SR-p53 | 0.212 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.